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ABSTRACT 
Squalestatin1 (SQ1), a potent inhibitor of squalene synthase produced a dose-dependent 
induction of cytochromes P450 CYP2H1 and CYP3A37 mRNAs in chicken hepatoma cells. The 
effect of SQ1 was completely reversed by 25-hydroxycholesterol. Bile acids elicited an induction 
of CYP3A37 and CYP2H1 mRNA. Bile acids also reduced the phenobarbital induction of 
CYP2H1 but not of CYP3A37 mRNA. The effects of SQ1 and its reversal by 25-
hydroxycholesterol and the effects of bile acids were reproduced in reporter gene assays with a 
phenobarbital-responsive enhancer unit of CYP2H1. These data suggest that an endogenous 
molecule related to cholesterol homeostasis regulates induction of drug-inducible CYPs. 
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INTRODUCTION 
 
Drug-mediated induction of cytochrome P450 hemeproteins (CYPs) has major effects on the 
biotransformation of endogenous and exogenous molecules including steroid hormones, bile 
acids, leukotrienes and xenobiotics such as most drugs. Phenobarbital (PB) is the prototype of a 
large group of small, lipophilic molecules regulating the drug- and steroid-metabolizing CYP2B, 
CYP2C and CYP3A subfamilies (1, 2). PB induction is observed in all species including plants, 
fish, birds, insects and mammals, with the notable exception of yeast (3). These observations 
have led us to speculate that PB induction of CYPs involves an endogenous regulation common 
to all living organisms (4). Recently, enhancer regions in the 5'-flanking region of PB-inducible 
CYPs have been isolated in chicken, rat, mouse and humans and DNA-binding proteins 
associated with these elements have been identified (for reviews, see refs. 1, 5). Members of the 
nuclear receptor superfamily, in particular the pregnane X receptor (PXR) and the constitutive 
androstane receptor (CAR) in mammals (1) and the chicken xenobiotic receptor (CXR) (6) are 
transcription factors that mediate the drug-response. These receptors have considerable overlap 
in their inducer profiles and can interchangeably bind to their respective response elements even 
across species boundaries (7). Interestingly, CAR, PXR and CXR belong to the family of orphan 
nuclear receptors comprising also receptors involved in cholesterol homeostasis, namely the 
oxysterol receptor LXR (liver X receptor) and the bile acid receptor (BAR, alternatively also 
designated FXR) (8). Moreover, all these receptors form heterodimers with the retinoid X 
receptor (RXR) for binding to their recognition sequences. 
 
In the absence of uptake of exogenous cholesterol, intracellular cholesterol content is controlled 
via two interconnected pathways. The mevalonate pathway ensures the de novo synthesis of 
cholesterol from acetyl-coA whereas the bile acid pathway transforms cholesterol into 
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hydroxylated metabolites leading to the primary bile acids, chenodeoxycholic acid (CCA) and 
cholic acid (CA) (reviewed in refs. 9-11). The regulation of both pathways occurs via negative 
feedback control loops activated by their respective end products (cholesterol or oxysterols for 
the mevalonate pathway, and bile acids for cholesterol catabolism). The pathways are 
interconnected by the stimulatory action of oxysterols in the catabolic pathway via LXR (12) 
and the activation of BAR by bile acids which leads to inhibition of cholesterol metabolism (13, 
14).  
 
Previous observation by Kocarek et al. (15) with lovastatin, an inhibitor of 3-hydroxy-3-
methylglutaryl (HMG)-CoA reductase in rat hepatocyte primary cultures suggested a link 
between cholesterol homeostasis and regulation of drug-metabolizing enzymes. More recently, 
squalestatin1 (SQ1), a potent squalene synthase inhibitor was observed to induce the expression 
of PB-inducible rat CYPB1/B2, both in vivo and in vitro in rat hepatocytes (16). Moreover, the 
effect of SQ1 was reversed by oxysterols. However, the mechanism of this interaction remained 
unexplained. We therefore have further investigated the effects of SQ1, oxysterols and bile acids 
on CYP induction. 
 
In the experiments described here, we have compared the effect of SQ1, oxysterols and bile acids 
on both the basal and inducible expression of representatives of two avian PB-inducible CYP 
subfamilies, CYP2H1 and CYP3A37, in a chicken hepatoma cell line (LMH). These cells retain 
the unique property of being inducible by PB-type xenobiotics in contrast to mammalian 
hepatoma cells (7). We show that SQ1 potently induces both CYPs and shares signalling 
pathways with the PB regulation of these genes. Moreover, we discovered that bile acids also 
induce CYP2H1 and confirm recent data in mammals that bile acids regulate CYP3A (17, 18). 
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Our data suggest that an endogenous molecule related to cholesterol homeostasis interacts with 
the PB-response enhancer sequences (PBRUs) in the 5'-flanking region of PB-inducible CYPs. 
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MATERIALS AND METHODS 
 
Reagents: Phenobarbital sodium salt was obtained from Fluka, Buchs, Switzerland. 
Tripotassium squalestatin1 was kindly provided by Glaxo-Welcome, Stevenage, Hertfordshire, 
UK. 25-hydroxycholesterol, cholic acid and chenodeoxycholic acid were from Sigma Chemicals, 
Buchs, Switzerland. Cell culture mediums and supplements, Trizol Reagent and fetal calf serum 
were obtained from Gibco-BRL, Life Technologies, Basel, Switzerland. 
 
Cell culture conditions and transfection: LMH cells were cultured and transfected as 
described previously (7). For induction experiments, cells were seeded at 80-90% confluence 
and after attachment, maintained in fetal calf serum deprived medium for 48 hours in order to 
eliminate any cholesterol exogenous sources. During this period, the medium was renewed at 
least once. Cells were then treated with the inducers at the indicated concentrations in serum-free 
medium. After 16 or 24 hours incubation, cells were collected using the Trizol reagent’s 
manufacturer procedure. 
 
RNA isolation and semiquantitative PCR analysis: RNA from LMH cells was isolated with 
the RNeasy Kit (Qiagen AG, Basel, Switzerland). One g total RNA was reverse-transcribed 
with the MMLV reverse transcriptase (Roche Molecular Biochemicals, Rotkreuz, Switzerland). 
PCR was performed using the Taqman PCR Core Reagent Kit (PE Applied Biosystems, 
Rotkreuz, Switzerland) and the transcript level quantitated with an ABI PRISM 7700 Sequence 
Detection System (PE Applied Biosystems, Rotkreuz, Switzerland) according to the 
manufacturers protocol. Briefly, relative transcript levels in induced cells and non-treated control 
cells were determined using the relative quantitation method measuring the Ct. The following 
primers and fluorescent probes were used in these PCR reactions: CYP2H1: probe 5’ TCG CAG 
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TTG CCT CCA GGT CTC CC 3’, forward primer 5’ AGG GTG GTG AGG GCA AAT C 3’, 
reverse primer 5’ ACA GGC ATT GTG ACC AGC AA 3’, CYP3A37: probe 5’ TTG GCC CAG 
GAA TGC CCA GCT 3’, forward primer 5’ GTC CCA AAG AAA GGC AAT GGT 3’, reverse 
primer 5’ GGC CAT TTG GGT TGT TCA AG 3’, glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH): probe 5’ TGG CGT GCC CAT TGA TCA CAA GTT T 3’, forward primer 5’ GGT 
CAC GCT CCT GGA AGA TAG T 3’, reverse primer 5’ GGG CAC TGT CAA GGC TGA GA 
3’. CYP2H1, CYP3A37 and GAPDH transcript levels were measured in separate tubes and 
GAPDH was used for normalisation of the CYP2H1 and the CYP3A37 values. 
 
Plasmids: pSRE-luc was a generous gift of Dr. A. Miserez, University Hospital, Basel. This 
vector contains the promoter of the human HMG CoA synthase gene including a canonical sterol 
responsive element (SRE). The 264bp-pBLCAT5 vector has already been described (19) and 
represents the phenobarbital-responsive unit of CYP2H1. The amplified fragment was inserted 
into the pBLCAT5 vector. Empty vectors were used as control plasmids. 
 
Reporter gene assays: For luciferase (LUC) containing constructs, reporter gene analysis was 
performed according to the manufacturers protocol (Luciferase assay system, Promega, Madison, 
WI, USA). Cells were washed with PBS and lysed in 100 µl of reporter lysis buffer (Promega). 
Lysates were cleared by centrifugation and assayed for luciferase activity with the Luciferase 
Assay System (Promega) and -gal activity with the substrate chlorophenol red--D-
galactopyranoside. Luciferase values normalised to the -gal activity in the extracts are referred 
to as luciferase units. For CAT containing constructs, cells were harvested using the protocol and 
reagents of the CAT-ELISA kit (Roche Diagnostics, Rotkreuz, Switzerland). Protein content of 
the cell extracts were also measured for the determination of the relative protein concentrations 
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using the ESL protein assay (Roche Diagnostics, Rotkreuz, Switzerland). This value was used 
for normalisation of specific CAT expression to total protein content. 
 
Page 10 of 22 
RESULTS 
 
SQ1 is an inducer of CYP2H1 and CYP3A37 mRNAs in LMH cells. LMH cells were 
maintained in chemically defined medium and in the absence of fetal calf serum at confluency 
for several days without visible toxicity. Under these conditions, LMH cells were treated with 
various doses of PB and SQ1. PB induced the mRNA of both CYP2H1 and CYP3A37 in a dose-
dependent manner, as previously described (19, 20). SQ1 induced the mRNA of both genes with 
a nearly maximal effect at 1 M, the induction of CYP2H1 by SQ1 was approximately one-third 
of the response to PB, whereas CYP3A37 mRNA was induced to equal levels by both inducers. 
When LMH cells were cultured in the presence of 10% fetal calf serum (FCS), PB induction was 
unchanged, but the SQ1 effect was much lower, showing a weak activation of CYP2H1 only at 
10 M (data not shown). In the absence of serum, SQ1 thus is the most potent inducer of 
CYP2H1 and CYP3A37 so far known with an effect in the low micromolar range in LMH cells 
(Fig. 1A). 
 
SQ1 induction is reversed by oxysterols: If SQ1 acts through cholesterol depletion, its effect 
should be reversed by oxysterols. PB induction of CYP2H1 and CYP3A37 was unaffected by 
coincubation with 25-hydroxycholesterol (25 OHC). In sharp contrast, SQ1 induction was 
completely abolished by coincubation with 20 M of 25 OHC (Fig. 1B). 
 
Control of cholesterol depletion in LMH cells: Depletion in intracellular sterols triggers the 
expression of several key enzymes of cholesterol synthesis. This occurs via the activation of 
SREBPs (sterol response element binding proteins), which are able to bind and transactivate 
sterol responsive elements (SREs) located in the regulatory regions of these genes (10). To test 
for sterol depletion in LMH cells, we used a reporter gene construct (pSRE-luc) containing the 
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SRE enhancer sequence of the human HMG-CoA synthase gene in front of a luciferase gene. 
SQ1 resulted in a dose-dependent up-regulation of reporter gene expression in LMH cells 
implying the activation of endogenous chicken SREBPs already at 100 nM concentration (Fig. 
2). This activation was reversed by coincubation with increasing concentrations of 25 OHC. PB 
had no effect on reporter gene expression (data not shown). These data indicate that SQ1 
effectively blocks cholesterol production in LMH cells. 
 
Bile acids are regulators of CYP expression: CCA and CA are the two major primary bile 
acids formed from cholesterol both in mammals and chicken (21, 22). CCA and CA have a 
regulatory role in cholesterol homeostasis by activating the bile acid receptor BAR and this 
affects the expression of CYP7A. CYP7A is the rate-limiting enzyme in bile acid formation, 
catalysing the biotransformation of cholesterol to 7-hydroxycholesterol. LMH cells were 
treated with bile acids alone or in combination with SQ1 and PB. Surprisingly, the effect on 
CYP2H1 and CYP3A37 mRNA was opposite. CCA and CA had little effect on CYP2H1 mRNA 
except at 100 M where they induce its mRNA several fold (Fig.3A). Moreover, when incubated 
together with SQ1 or PB, bile acids produced a dose-dependent inhibition of induction. In 
contrast, CYP3A37 mRNA was strongly induced by bile acids (Fig.3B). In particular, CCA (50 
M) induced higher levels of CYP3A37 mRNA than SQ1 or PB at 50 M. CCA did not 
influence the effects of SQ1 or PB at concentrations below 20 M but induced CYP3A37 
mRNA in an additive fashion at higher concentrations. CA has a similar but weaker effect (Fig. 
3B). 
 
Squalestatin1 and bile acid effects act at the transcriptional level: We have defined a 
regulatory element in the 5’ flanking region of the CYP2H1 gene (19). This element spans 264bp 
and is located at approximately -1600bp upstream of the transcription start site of CYP2H1 and 
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is responsive to PB. It contains a DR4 like motif neighbouring a putative nuclear factor-1 (NF-1) 
site. This motif is common to other PBRUs found in PB-regulated genes (7, 19, 23). SQ1 
transactivated this element and 25 OHC completely abolished this effect (Fig. 4A). At the 
reporter gene level, the effect of PB also was partially inhibited by oxysterols. When bile acids 
were incubated with transfected cells, a weak activation of reporter gene expression was 
observed with CCA alone as at the mRNA level (Fig.4B). Coexposure to CCA and PB resulted 
in an inhibition of PB induction to the level of CCA alone. 
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DISCUSSION 
 
The data presented here demonstrate that cholesterol homeostasis regulators such as bile acids 
and oxysterols affect both the basal and induced levels of two drug-inducible CYPs, namely 
CYP2H1 and CYP3A37. This is demonstrated by results obtained at the mRNA level in LMH 
cells, a hepatoma cell line that uniquely maintains PB-type induction of several cytochromes 
P450 (7, 19). In these cells, SQ1, an inhibitor of squalene formation and thereby cholesterol 
synthesis, is the most potent inducer of CYP2H1 and CYP3A37 so far tested. SQ1 has been 
chosen as an inhibitor of cholesterol biosynthesis because of its high specificity for squalene 
synthase, a late enzyme in the mevalonate pathway. SQ1 inhibition affects specifically the sterol 
production in the cell in contrast to the multiple effects of so-called “statins“ such as lovastatin 
(16). SQ1 induced CYP2H1, but also CYP3A37, a typical member of the CYP3A subfamily 
(20). SQ1 indirectly or directly activated a PBRU of 264 bp in reporter gene assays (19), 
imitating the effects of phenobarbital-type inducers. The fact that the effect of SQ1 on mRNA 
and on PBRU is reversed by oxysterols suggests an indirect mechanism. The data also suggest 
that SQ1 and PB are acting on CYP2H1 and CYP3A37 via a different mechanisms because the 
effect of PB is not reversed by oxysterols. Induction by SQ1 correlates with its inhibitory action 
on cholesterol biosynthesis as evidenced by activation of SREBPs, which also is fully reversed 
by oxysterols. We therefore hypothesise that endogenous sterols (such as hydroxycholesterol 
derivatives) negatively regulate the transcription of these CYP genes by interaction with the 
PBRU. It is of interest that no canonical SRE elements are contained in this sequence. Oxysterols 
transactivate the nuclear receptor LXR which binds to a nuclear receptor hexamer repeat 
sequence arranged as direct repeat spaced by 4 nucleotides (DR4) (24). Indeed, the 264bp PBRU 
contains a DR4 element as a recognition site for CXR that is involved in PB-responsiveness (6, 
19). This avian PBRU also recognises the mammalian receptors CAR and PXR which all form 
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heterodimers with RXR for binding to this element and in all cases, a DR4 element is of 
importance (6, 7). Thus, there may be competition between CXR/RXR and LXR/RXR and this 
could explain that the PB-induction of CYP2H1 is dependent on oxysterol levels. We are testing 
this hypothesis at present. 
 
The effect of bile acids is more pronounced with CYP3A than with CYP2H1 and confirms recent 
results that some mammalian CYPs, e.g. CYP3A4 are induced by bile acids (17, 18). Primary 
bile acids are major products of cholesterol catabolism, synthesised specifically in the hepatocyte 
(21). These compounds have detergent properties and consequently, their accumulation is 
potentially deleterious for cells. Metabolism of bile acids to non-toxic, excretable products may 
represent an adaptable protective pathway against this toxicity (25). The concentrations of the 
primary bile acids used in our experiments correspond to the concentrations occurring in bile. 
The dose-dependent effect of bile acids on CYP3A37 induction could thus be a detoxification 
reaction similar to the protective effect of drug metabolism against drug toxicity. The effect of 
bile acids on CYP2H1 appears to be more difficult to interpret. At low concentrations (10 M), 
the inducibility of CYP2H1 and CYP3A37 by SQ1 or PB is inhibited. At higher concentrations 
(100 M), this effect appears to be compensated by induction of these enzymes. The inhibitory 
effect of bile acids differs from that of 25 OHC because it affects both SQ1 and PB induction. 
 
The observation of cross-talk between regulators of cholesterol homeostasis and drug- and 
xenobiotic-mediated changes in CYP transcription may have important clinical implications. A 
review of the literature indeed suggests numerous so far unexplained interactions between 
cholesterol homeostasis and drug metabolism. Rats with high cholesterol levels in the liver, for 
instance rats exposed to a high cholesterol diet, or rats with spontaneous hyperlipidemia have a 
markedly decreased expression of basal and PB-induced CYPs as compared to controls (26, 27). 
Page 15 of 22 
Furthermore, treatment of epileptic patients or rodents with PB results in increased plasma 
cholesterol and lipoproteins (see ref. 28 and references therein). It also is well established but 
mechanistically unexplained that patients with cholestasis benefit from treatment with PB and 
rifampicin (29, 30). The present studies now offer first insights into the mechanisms that underlie 
the interactions between cholesterol homeostasis and drug effects on CYPs. 
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FIGURE LEGENDS 
 
Figure 1: Effect of squalestatin1 (SQ1) on CYP2H1 and CYP3A37 mRNAs. LMH cells, 
cultured in the absence of serum, were treated with the indicated doses of phenobarbital (PB) or 
SQ1 in the absence (A) or presence (B) of 20 M 25-hydroxycholesterol (25 OHC). After 16 
hours, CYP2H1, CYP3A37 and GAPDH mRNA levels were determined by real-time PCR 
analysis. The relative expression of each gene is given as fold induction by comparison to 
untreated samples, and standardised according the expression of GAPDH mRNA. Each value 
represents the mean and standard deviation of at least three independent experiments. 
 
Figure 2: Activation of a sterol responsive element (SRE)-containing reporter construct by 
squalestatin1 (SQ1) and its reversibility by 25-hydroxycholesterol (25 OHC). LMH cells 
were transfected with pSRE-luc as described in Material and Methods. After removal of fetal 
calf serum for 24 hours, cells were treated with increasing doses of SQ1 or a constant dose of 
SQ1 and increasing doses of 25 OHC. Each value represents the average and standard deviation 
of triplicate samples and is expressed in relative light unit standardised against an empty pluc 
vector. The data are derived from one representative experiment of several independent ones. 
 
Figure 3: Effect of bile acids on CYP2H1 and CYP3A37 mRNA. LMH cells were treated 
with increasing doses of chenodeoxycholic acid (CCA) or a single dose of cholic acid (CA) 
alone or in combination with squalestatin1 (SQ1, 10M) or phenobarbital (PB, 500M). 
CYP2H1 (A) or CYP3A37 (B) mRNA levels are represented as fold induction compared to 
untreated samples. Each value is the average of duplicate samples. The data represent the mean 
and standard deviation of three independent experiments. 
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Figure 4: Transcriptional activation of CYP2H1 phenobarbital responsive unit (PBRU) by 
squalestatin 1 (SQ1) and bile acids. LMH cells were transfected with a reporter gene construct 
containing the 264bp phenobarbital responsive enhancer unit of CYP2H1 in front of the 
chloramphenicol acetyltransferase gene. The transfected cells were treated with SQ1 in the 
presence or absence of 25-hydroxycholesterol (25 OHC, 20M) (A) or with chenodeoxycholic 
acid (CCA, 10 M) or cholic acid (CA, 10 M) alone or in combination with SQ1 or 
phenobarbital (PB) (B). The data are expressed as the mean and standard deviation of four 
independent experiments. 
 




